// App-Quantinova.ai

: The Value of FDP/FIB and D-Dimer/FIB Ratios: Predicting High-Risk APL Related Thrombosis

Researchers

Presenter

  • Yanliang Bai

Principal Investigators

  • Mingyue Shi

  • Wanjun Zhang

  • Xiawan Yang

  • Hafiz Abdul Waqas Ahmed

  • Lei Huo

  • Yuqing Chen

  • Xiaona Niu

  • Honggang Guo

  • Fangfang Xu

  • Jing Yang

  • Yuzhu Zang

  • Shuangyin Han

  • Kai Sun

Medical Centers

  • N/A

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute promyelocytic leukemia

  • Stroke

  • Venous thrombosis

Biomarkers

  • N-Acylethanolamine acid amidase

  • D-dimer

  • Lymphocyte count

  • White Blood Cell

  • Activated partial thromboplastin time

Drug/Treatment

  • Tretinoin

  • Arsenic trioxide

  • arsenic

  • Hydroxycarbamide

  • Hemostatic Solution

  • Idarubicin Hydrochloride

  • PT-15

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved